Search

Search Constraints

You searched for: Author/Creator Mahalingam, Devalingam

Search Results

1. 374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors. (10th December 2020)

2. 374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors. (9th November 2020)

3. A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsy. Issue 9 (23rd May 2011)

4. A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01. Issue 19 (27th July 2022)

6. Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up. (28th May 2019)

7. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. Issue 11 (17th April 2017)

8. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. Issue 9 (6th January 2016)

9. Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancer. Issue 13 (25th July 2014)

10. Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma. Issue 1 (4th October 2022)